Identification of functional regulatory elements in the human genome using pooled CRISPR screens

被引:13
作者
Borys, Samantha M. [1 ]
Younger, Scott T. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[2] Childrens Mercy Kansas City, Ctr Pediat Genom Med, Kansas City, MO 64108 USA
[3] Childrens Mercy Kansas City, Childrens Mercy Res Inst, Kansas City, MO 64108 USA
[4] Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66160 USA
[5] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64110 USA
关键词
CRISPR; CRISPR screen; Regulatory element; Enhancer; p53; CHECKPOINT RESPONSE; GENETIC SCREENS; P53; ACTIVATION; TRANSCRIPTION; DESIGN;
D O I
10.1186/s12864-020-6497-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Genome-scale pooled CRISPR screens are powerful tools for identifying genetic dependencies across varied cellular processes. The vast majority of CRISPR screens reported to date have focused exclusively on the perturbation of protein-coding gene function. However, protein-coding genes comprise < 2% of the sequence space in the human genome leaving a substantial portion of the genome uninterrogated. Noncoding regions of the genome harbor important regulatory elements (e.g. promoters, enhancers, silencers) that influence cellular processes but high-throughput methods for evaluating their essentiality have yet to be established. Results Here, we describe a CRISPR-based screening approach that facilitates the functional profiling of thousands of noncoding regulatory elements in parallel. We selected the tumor suppressor p53 as a model system and designed a pooled CRISPR library targeting thousands of p53 binding sites throughout the genome. Following transduction into dCas9-KRAB-expressing cells we identified several regulatory elements that influence cell proliferation. Moreover, we uncovered multiple elements that are required for the p53-mediated DNA damage response. Surprisingly, many of these elements are located deep within intergenic regions of the genome that have no prior functional annotations. Conclusions This work diversifies the applications for pooled CRISPR screens and provides a framework for future functional studies focused on noncoding regulatory elements.
引用
收藏
页数:15
相关论文
共 36 条
  • [1] Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
    Allen, Mary Ann
    Andrysik, Zdenek
    Dengler, Veronica L.
    Mellert, Hestia S.
    Guarnieri, Anna
    Freeman, Justin A.
    Sullivan, Kelly D.
    Galbraith, Matthew D.
    Luo, Xin
    Kraus, W. Lee
    Dowell, Robin D.
    Espinosa, Joaquin M.
    [J]. ELIFE, 2014, 3
  • [2] [Anonymous], 2018, NAT COMMUN, DOI DOI 10.1038/s41467-018-07901-8
  • [3] Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer
    Attardi, LD
    de Vries, A
    Jacks, T
    [J]. ONCOGENE, 2004, 23 (04) : 973 - 980
  • [4] TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
    Bouaoun, Liacine
    Sonkin, Dmitriy
    Ardin, Maude
    Hollstein, Monica
    Byrnes, Graham
    Zavadil, Jiri
    Olivier, Magali
    [J]. HUMAN MUTATION, 2016, 37 (09) : 865 - 876
  • [5] BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
    Canver, Matthew C.
    Smith, Elenoe C.
    Sher, Falak
    Pinello, Luca
    Sanjana, Neville E.
    Shalem, Ophir
    Chen, Diane D.
    Schupp, Patrick G.
    Vinjamur, Divya S.
    Garcia, Sara P.
    Luc, Sidinh
    Kurita, Ryo
    Nakamura, Yukio
    Fujiwara, Yuko
    Maeda, Takahiro
    Yuan, Guo-Cheng
    Zhang, Feng
    Orkin, Stuart H.
    Bauer, Daniel E.
    [J]. NATURE, 2015, 527 (7577) : 192 - +
  • [6] Chikayama S, 2000, INT J ONCOL, V16, P1117
  • [7] Multiplex Genome Engineering Using CRISPR/Cas Systems
    Cong, Le
    Ran, F. Ann
    Cox, David
    Lin, Shuailiang
    Barretto, Robert
    Habib, Naomi
    Hsu, Patrick D.
    Wu, Xuebing
    Jiang, Wenyan
    Marraffini, Luciano A.
    Zhang, Feng
    [J]. SCIENCE, 2013, 339 (6121) : 819 - 823
  • [8] Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
    Doench, John G.
    Fusi, Nicolo
    Sullender, Meagan
    Hegde, Mudra
    Vaimberg, Emma W.
    Donovan, Katherine F.
    Smith, Ian
    Tothova, Zuzana
    Wilen, Craig
    Orchard, Robert
    Virgin, Herbert W.
    Listgarten, Jennifer
    Root, David E.
    [J]. NATURE BIOTECHNOLOGY, 2016, 34 (02) : 184 - +
  • [9] Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation
    Doench, John G.
    Hartenian, Ella
    Graham, Daniel B.
    Tothova, Zuzana
    Hegde, Mudra
    Smith, Ian
    Sullender, Meagan
    Ebert, Benjamin L.
    Xavier, Ramnik J.
    Root, David E.
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (12) : 1262 - U130
  • [10] Flatt PM, 1998, CELL GROWTH DIFFER, V9, P535